Company Filing History:
5 out of 989 
4 out of 81 
1 out of 832,912 Years Active: 2019-2025
Title: Innovations of Anne Hotard in Respiratory Syncytial Virus Research
Introduction
Anne Hotard is a prominent inventor based in Atlanta, GA, known for her significant contributions to the field of virology, particularly in the study of respiratory syncytial virus (RSV). With a total of six patents to her name, she has made remarkable strides in developing vaccines and methods related to RSV.
Latest Patents
Among her latest patents is the invention titled "Recombinant RSV with silent mutations, vaccines, and methods related thereto." This patent focuses on the polynucleotide sequences of RSV and includes isolated or recombinant nucleic acids and polypeptides that comprise desirable nucleic acid sequences and mutations. The patent also discusses the provision of attenuated recombinant RSV, immunogenic compositions, and RSV genomes suitable for use as vaccines. Additionally, it contemplates attenuated or killed RSV containing these nucleic acids and mutations in the form of copied nucleic acids, such as cDNAs.
Career Highlights
Anne has worked with esteemed institutions such as Emory University and Children's Healthcare of Atlanta, Inc. Her work has been pivotal in advancing the understanding and treatment of RSV, a virus that poses significant health risks, especially to infants and young children.
Collaborations
Throughout her career, Anne has collaborated with notable colleagues, including Martin L. Moore and Jia Meng. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Anne Hotard's innovative work in the realm of respiratory syncytial virus research has led to significant advancements in vaccine development and virology. Her contributions continue to impact public health positively.